Market Access & HEOR

Our team brings together deep industry experience and analytical expertise to navigate complex healthcare systems, payer requirements, and regulatory environments. From early-phase strategy to post-launch optimisation, we partner with clients to ensure every decision is supported by robust data and tailored market insights.

• Proven track record across multiple therapeutic areas and geographies.
• Multidisciplinary team combining scientific, strategic, and market expertise.
• Commitment to excellence, transparency, and competitive pricing.

Together, we help transform evidence into impact – empowering clients to bring life-changing innovations to patients around the world.

The landscape of market access in the Middle East, Africa and Asia-Pacific is undergoing a significant transformation. At R-S-S, our specialised market access consulting services empower our clients to develop effective strategies for market entry, engage with payers, and communicate value across the Middle East, Africa and Asia-Pacific.

Each country in Asia has its own unique regulatory framework. Our experts also have experience in dealing with these markets, working with regulatory bodies like National Medical Products Administration (NMPA), Pharmaceuticals and Medical Devices Agency (PMDA) and Ministry of Food and Drug Safety of the Republic of Korea (MFDS).

Partner with us to navigate the evolving market access landscape and achieve success in the Middle East and Asia.

At R-S-S, we support your engagement with the European Union’s Joint Clinical Assessment (JCA) process by offering comprehensive expertise navigating its rigorous and collaborative framework. The JCA is a centralised evaluation conducted under the EU HTA Regulation, providing scientific assessments of the relative clinical effectiveness and safety of new health technologies across member states.

Our team can assist you in preparing and submitting robust JCA dossiers by aligning evidence generation with the PICOS framework (Population, Intervention, Comparison, Outcome, Study design) essential for scoping and assessment. We help interpret and incorporate the JCA outputs to optimise market access strategies, ensuring your products are positioned effectively within diverse EU healthcare systems. Our support mitigates complexity by managing timelines, stakeholder consultations, and regulatory requirements, accelerating adoption and reimbursement decisions across Europe.